Search IPOs
Subscription Status · Mar 20 – Mar 24, 2026 · ₹117–124
Speciality Medicines IPO subscribed 2.27 times — as of Mar 24, 2026
The Speciality Medicines IPO subscription has recorded healthy investor demand with an overall subscription of 2.27× as of Mar 24, 2026, indicating that investors applied for 2.27 times the number of shares on offer. All investor categories — institutional, HNI, and retail — have participated actively, making this one of the closely watched IPO openings.
As of March 24, 2026
| Category | Shares Offered | Shares Bid For | Times Subscribed | Applications |
|---|---|---|---|---|
|
QIB
Qualified Institutional Buyers
|
21,000 | 2,021,000 |
96.24×
|
— |
|
NII
Non-Institutional Investors
|
1,089,000 | 2,044,000 |
1.88×
|
— |
|
bNII
Bids above ₹10L
|
726,000 | 1,813,000 |
2.50×
|
— |
|
sNII
Bids below ₹10L
|
363,000 | 231,000 |
0.64×
|
— |
|
Retail
Retail Individual Investors
|
1,090,000 | 922,000 |
0.85×
|
— |
|
Total
|
2,200,000 | 4,987,000 |
2.27×
|
— |
How subscription built up across investor categories over time
Snapshot of each day's bidding activity
| Category | Offered | Bid For | Times | Applications |
|---|---|---|---|---|
| QIB | 21,000 | 2,021,000 | 96.24× | — |
| NII | 1,089,000 | 2,044,000 | 1.88× | — |
| bNII | 726,000 | 1,813,000 | 2.50× | — |
| sNII | 363,000 | 231,000 | 0.64× | — |
| Retail | 1,090,000 | 922,000 | 0.85× | — |
| Total | 2,200,000 | 4,987,000 | 2.27× | — |
| Category | Offered | Bid For | Times | Applications |
|---|---|---|---|---|
| QIB | 21,000 | 21,000 | 1.00× | — |
| NII | 1,089,000 | 1,832,000 | 1.68× | — |
| bNII | 726,000 | 1,795,000 | 2.47× | — |
| sNII | 363,000 | 37,000 | 0.10× | — |
| Retail | 1,090,000 | 212,000 | 0.19× | — |
| Total | 2,200,000 | 2,065,000 | 0.94× | — |
| Category | Offered | Bid For | Times | Applications |
|---|---|---|---|---|
| QIB | 21,000 | 21,000 | 1.00× | — |
| NII | 1,089,000 | 1,745,000 | 1.60× | — |
| bNII | 726,000 | 1,723,000 | 2.37× | — |
| sNII | 363,000 | 22,000 | 0.06× | — |
| Retail | 1,090,000 | 72,000 | 0.07× | — |
| Total | 2,200,000 | 1,838,000 | 0.84× | — |
As of March 24, 2026, the Speciality Medicines IPO has been subscribed 2.27 times overall. The IPO is fully subscribed.
The Speciality Medicines IPO subscription window was open from March 20, 2026 to March 24, 2026. Investors could apply through their demat account or ASBA facility.
The Speciality Medicines IPO has a price band of ₹117 to ₹124 per share, with a lot size of 1,000 shares. Minimum retail investment: ₹117,000 (lower band) or ₹124,000 (upper band).
The QIB category has been subscribed 96.24 times. QIBs were offered 21,000 shares. Strong QIB subscription indicates high institutional confidence.
Retail investors subscribed 0.85 times. Retail was offered 1,090,000 shares. Below 1× indicates moderate retail interest.
Overall NII: 1.88×. bNII (>₹10L): 2.50×, sNII (<₹10L): 0.64×. NII includes HNIs and corporate entities investing above ₹2 lakh.
Basis of allotment is on March 25, 2026. Check via the registrar's website — Skyline Financial Services Pvt.Ltd. using your PAN number, application number, or DP/Client ID. You can also check on BSE/NSE websites or through your broker's app.
Speciality Medicines IPO is expected to list on March 30, 2026. Shares will list on BSE SME platform. Allotted shares are credited to your demat account 1 business day before listing.
A subscription multiple of 2.27× means investors have bid for 2.27 times the total shares available. Since the IPO is oversubscribed, not every applicant will receive shares — allotment happens via lottery (for retail) or proportionately (for other categories). Higher multiples generally reduce allotment probability.
Based on the current retail subscription of 0.85×, the estimated allotment probability for retail investors is High. Applicants likely to get full allotment. If final subscription stays below 1×, all applicants are likely to get full allotment.
You can apply for Speciality Medicines IPO through: (1) ASBA (Application Supported by Blocked Amount) via your bank's net banking or mobile app, (2) UPI-based application through your broker's app (Zerodha, Groww, Angel One, etc.), or (3) directly via your demat account. The amount is blocked in your account and deducted only upon allotment. Applications were accepted from Mar 20 to Mar 24, 2026.
The grey market premium (GMP) reflects unofficial pre-listing trading sentiment. For the latest Speciality Medicines IPO GMP data, check the IPO Rise GMP page. Note: GMP is unofficial, speculative, and not a guaranteed indicator of listing price — use it only as a sentiment signal alongside official subscription data.
The Speciality Medicines IPO subscription tracks how many times each investor category has subscribed relative to their reserved quota. As of Mar 24, 2026, the overall subscription stands at 2.27× — Oversubscribed.
QIBs include domestic mutual funds, FIIs/FPIs, banks, insurance companies, and SEBI-registered venture capital funds. They are allocated up to 50% of the net offer (75% for SME IPOs). For Speciality Medicines IPO, QIB subscription is at 96.24×. High QIB subscription signals strong institutional conviction and is considered a positive indicator for post-listing performance.
NIIs are high-net-worth individuals (HNIs) and corporate bodies applying for more than ₹2 lakh. SEBI further divides this into bNII (bids above ₹10 lakh) and sNII (bids between ₹2–10 lakh), each with a separate allotment bucket. For Speciality Medicines IPO: bNII at 2.50×, sNII at 0.64×. Very high NII subscription (>50×) often signals leveraged HNI bidding, suggesting a strong listing expectation.
Retail investors apply for up to ₹2 lakh. They are reserved 35% of the net offer (in most mainboard IPOs). If oversubscribed, allotment is via computerised lottery — each applicant (regardless of lot count) has an equal probability. Speciality Medicines IPO retail subscription: 0.85×.
Price band: ₹117–₹124 per share. Lot size: 1,000 shares. Minimum retail investment at upper band: ₹124,000. Applications must be in multiples of 1,000 shares.
Stock exchanges (BSE/NSE) publish subscription data multiple times a day during the subscription window. The figures shown here represent the latest available snapshot. "Shares Offered" is the quota reserved for each category; "Shares Bid For" is the total demand received; "Times Subscribed" is the ratio of demand to supply.
Subscription Opens Done
Mar 20, 2026Subscription Closes Done
Mar 24, 2026Basis of Allotment Done
Mar 25, 2026Listing on BSE Done
Mar 30, 2026Applicants likely to get full allotment. Based on retail subscription of 0.85×.
Share Subscription Card
Download a branded image to share on WhatsApp, Twitter, or Telegram
Higher subscription = lower allotment probability. Progress bars compare each category relative to the highest-subscribed category.